MBX Biosciences, Inc. (MBX) stock forecast — our track record
3 completed MBX stock predictions — wins and misses, nothing deleted. Each forecast was published before the outcome was known.
How our MBX forecasts have done
Lyra published 3 MBX stock forecasts starting December 5, 2025. Each prediction was published before the outcome was known. All used the short-term horizon (0 to 3 months), and every forecast is now closed and scored. This track record is small.
All 3 predictions reached their targets, and none of them missed. The average success score was 100%. The short-term calls also had an average score of 100%.
The best call was published December 5, 2025. It predicted 38% growth, and the stock rose as much as 44.9%, reaching the target in 40 days. The worst call was published January 12, 2026. It predicted 25% growth, and the stock rose as much as 32.9%, reaching the target in 2 days. Both received a 100% score. Overall, every call in this limited record reached its target.
Written from the closed signals below; refreshed when new signals close.
Closed MBX signals
| Closed | Timeframe | Predicted | At close | Peak result | Outcome | Days to target | |
|---|---|---|---|---|---|---|---|
| April 12, 2026 | |||||||
| March 9, 2026 | |||||||
| March 5, 2026 |
At close is the return from the publication price to the last close inside the signal’s measurement window — what the window actually delivered. Peak result is the highest point inside that window, labelled as peak because it is not a realized return.
Share this receipt
The full public record for this symbol — wins and misses. Paste the link anywhere — it unfurls as the card above.
See what we’re calling today.
Every published signal is scored against what the stock actually did — the same way MBX was. No deleted misses, no cherry-picking.